O’Nesha Cochran, a certified peer recovery mentor, shares her story and provides an overview of peer recovery support, how people interested in peer recovery can become certified, and potential barriers… […]
Audience: Clinical
Surveillance To Detect Hepatocellular Carcinoma | March 12, 2019
Incidence of hepatocellular carcinoma (HCC) is rising quickly in the United States, and AI/AN people are being affected greater than any other group. Dr. Brian McMahon, Director of the Liver… […]
Read More… from Surveillance To Detect Hepatocellular Carcinoma | March 12, 2019
The Language of Addiction | March 7, 2019
Dr. Karla Thornton, Professor of Infectious Diseases at the University of New Mexico Health Sciences Center, speaks about the importance of using non-stigmatizing language in substance use and shares the… […]
Addressing the Evolving Opioid and HCV Epidemics | February 27, 2019
Annette Hewitt, Nurse Practitioner for the Liver Disease and Hepatitis Program at the Alaska Native Tribal Health Consortium, explains parallels between the opioid and HCV epidemics. She also discusses harm… […]
Read More… from Addressing the Evolving Opioid and HCV Epidemics | February 27, 2019
Opioid Treatment Failure | February 21, 2019
Dr. Jonathan Robbins, an internal medicine physician at Oregon Health & Science University, speaks about the the universal precautions used in opioid prescribing, what opioid success and failure look like… […]
Read More… from Opioid Treatment Failure | February 21, 2019
Addiction Treatment and the HCV Provider | February 12, 2019
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, discusses the relationship between the opioid epidemic and HCV infections as well as the different treatments available… […]
Read More… from Addiction Treatment and the HCV Provider | February 12, 2019
Medications for OUD: Who Should Get What When? | February 7, 2019
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, compares buprenorphine, methadone, and extended release naltrexone in terms of efficacy, induction, retention, operational restraints, and other… […]
Read More… from Medications for OUD: Who Should Get What When? | February 7, 2019
HCV Elimination | January 23, 2019
Dr. Jorge Mera, Director of Infectious Diseases for the Cherokee Nation Health Service, provides a general overview of HCV elimination and micro-elimination, as well as an overview of the Cherokee… […]
Neurobiology and Diagnosis of SUDs | January 17, 2019
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, reviews the diagnostic criteria for substance use disorders and examines the different ways in which substance use… […]
Read More… from Neurobiology and Diagnosis of SUDs | January 17, 2019
The Impact of SVR on Cirrhosis and Non-Liver Complications | December 11, 2018
Annette Hewitt and Lisa Townshend-Bulson, Family Nurse Practitioners from the Alaska Native Tribal Health Consortium, Liver Disease & Hepatitis Program, present on the impact of sustained virologic response (SVR) on… […]
Read More… from The Impact of SVR on Cirrhosis and Non-Liver Complications | December 11, 2018
